Skip to main content
. 2017 Oct 11;56(23):3167–3172. doi: 10.2169/internalmedicine.9191-17

Table 4.

Serum OXT Levels before and after bDMARDs Treatment.

f value p value f value (0.95)
Interaction 0.102 0.752 4.085
Interindividual variation 0.659 0.422 4.085
Individual variation 0.729 0.398 4.085

Analysis by repeated measure ANOVA. OXT: oxytocin, bDMARD: biological disease-modifying antirheumatic drug, ANOVA: analysis of variance